Refinement of a Live Attenuated <i>Salmonella enterica</i> Serovar Newport Vaccine with Improved Safety
Non-typhoidal <i>Salmonella</i> (NTS) is a major cause of gastroenteritis and is responsible for approximately 93 million cases annually. In healthy individuals, gastroenteritis caused by NTS is usually self-limiting, however, NTS can cause severe invasive disease in immunocompromised pa...
Main Authors: | Shamima Nasrin, Fabien J. Fuche, Khandra T. Sears, Jennifer A. Jones, Myron M. Levine, Raphael Simon, Sharon M. Tennant |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/1/57 |
Similar Items
-
Phylogeny and Genomic Characterization of Clinical Salmonella enterica Serovar Newport Collected in Tennessee
by: Lauren K. Hudson, et al.
Published: (2023-02-01) -
Emerging colistin resistance in Salmonella enterica serovar Newport isolates from human infections
by: Mohammed Elbediwi, et al.
Published: (2020-01-01) -
Geography, Antimicrobial Resistance, and Genomics of <i>Salmonella enterica</i> (Serotypes Newport and Anatum) from Meat in Mexico (2021–2023)
by: Eduardo Canek Reynoso, et al.
Published: (2024-12-01) -
Ceftriaxone-resistant Salmonella enterica serovar Newport: a case report from South India
by: Mahadevaiah Neelambike Sumana, et al.
Published: (2024-08-01) -
Ceftriaxone-Resistant Salmonella enterica Serotype Newport, France
by: Svetlana Egorova, et al.
Published: (2008-06-01)